HIGHLIGHTS
- who: Zuoquan Xie from the (UNIVERSITY) have published the article: Structural insights into a shared mechanism of human STING activation by a potent agonist and an autoimmune disease-associated mutation, in the Journal: (JOURNAL)
- what: The authors designed a new diABZI-based STING agonist HB3089 that triggers substantial antitumor immunity and exhibits robust anti-tumor activity. The authors took an approach of rational design based on diABZI compounds and obtained a more asymmetric diABZI structure, HB3089. The study provides useful structural information for the rational design of therapies for treating cancers or autoimmune disorders, through . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.